Consensus Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-15 pm EST			5-day change	1st Jan Change
559.52 ^USD	+3.17%		-1.30%	+7.20%

Dec. 12	Wells Fargo Adjusts Price Target on Intuitive Surgical to $654 From $600, Maintains Overweight Rating	MT
Dec. 11	Citigroup Downgrades Intuitive Surgical to Neutral From Buy, Adjusts Price Target to $635 From $650	MT

Evolution of the Average Target: Intuitive Surgical, Inc.

Evolution of the Target Price: Intuitive Surgical, Inc.

Changes in Analyst Recommendations: Intuitive Surgical, Inc.

19b05ac8b255a8bf0a7e8e4921b72e.XaJjJPRJKfX2i8HFH8gRnHo-ytcBncGOPUxIWS07yFY.MegEHLEIa7ym3ZaifP5iqS1EjL1V8o_3ai96AU9SqTEWxFIQmGRh2K65lA~d0fbb4192fdd97f7bba919a0d54e6883

Analysts' recommendations: Intuitive Surgical, Inc.

Dec. 12	Wells Fargo Adjusts Price Target on Intuitive Surgical to $654 From $600, Maintains Overweight Rating	MT
Dec. 11	Citigroup Downgrades Intuitive Surgical to Neutral From Buy, Adjusts Price Target to $635 From $650	MT
Oct. 27	Argus Research Adjusts Intuitive Surgical Price Target to $630 From $600	MT
Oct. 27	Analyst recommendations: Doordash, Five Below, Honeywell International, Microsoft, General Motors…
Oct. 27	William O'Neil Initiates Intuitive Surgical at Buy	MT
Oct. 24	Daiwa Securities Adjusts Price Target on Intuitive Surgical to $550 From $510, Maintains Outperform Rating	MT
Oct. 23	UBS Adjusts Intuitive Surgical Price Target to $600 From $585, Maintains Neutral Rating	MT
Oct. 23	Rothschild & Co Redburn Adjusts Intuitive Surgical Price Target to $615 From $610, Maintains Buy Rating	MT
Oct. 23	HSBC Adjusts Intuitive Surgical Price Target to $644 From $595, Maintains Buy Rating	MT
Oct. 22	Intuitive Surgical Q3 Results Show Robotic Surgery Market Fundamentals Remain Good, Deutsche Bank Says	MT
Oct. 22	Intuitive Surgical Shares Rise After Q3 Beat, Price Targets Raised	MT
Oct. 22	Baird Adjusts Intuitive Surgical Price Target to $655 From $536, Maintains Outperform Rating	MT
Oct. 22	Leerink Partners Adjusts Intuitive Surgical Price Target to $600 From $593, Maintains Outperform Rating	MT
Oct. 22	Piper Sandler Adjusts Intuitive Surgical Price Target to $610 From $595, Maintains Overweight Rating	MT
Oct. 22	Jefferies Adjusts Intuitive Surgical Price Target to $560 From $550, Maintains Hold Rating	MT
Oct. 22	Bernstein Adjusts Intuitive Surgical Price Target to $700 From $685, Maintains Outperform Rating	MT
Oct. 22	BTIG Research Adjusts Intuitive Surgical Price Target to $589 From $529, Maintains Buy Rating	MT
Oct. 22	Mizuho Securities Adjusts Intuitive Surgical Price Target to $575 From $520, Maintains Neutral Rating	MT
Oct. 22	Wells Fargo Adjusts Intuitive Surgical Price Target to $600 From $599, Maintains Overweight Rating	MT
Oct. 22	Goldman Sachs Adjusts Intuitive Surgical Price Target to $621 From $567, Maintains Buy Rating	MT
Oct. 22	Raymond James Adjusts Intuitive Surgical Price Target to $603 From $592, Maintains Outperform Rating	MT
Oct. 22	Evercore ISI Adjusts Intuitive Surgical Price Target to $540 From $450, Maintains In Line Rating	MT
Oct. 22	JPMorgan Adjusts Intuitive Surgical Price Target to $625 From $605, Maintains Overweight Rating	MT
Oct. 22	RBC Raises Price Target on Intuitive Surgical to $625 From $615, Keeps Outperform Rating	MT
Oct. 21	Intuitive Surgical beats Q3 revenue estimates	RE

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	INTUITIVE SURGICAL, INC.					+9.87%
	THERMO FISHER SCIENTIFIC, INC.					+10.42%
	DANAHER CORPORATION					+13.15%
	BOSTON SCIENTIFIC CORPORATION					+36.62%
	SIEMENS HEALTHINEERS AG					+29.43%
	EDWARDS LIFESCIENCES CORPORATION					+15.01%
	AGILENT TECHNOLOGIES, INC.					+21.3%
	GE HEALTHCARE TECHNOLOGIES INC.					+5.77%
	RESMED, INC.					+16.59%
	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.					+40.15%
	Average					+19.83%
	Weighted average by Cap.					+17.45%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

559.52USD

Average target price

597.71USD

Spread / Average Target

+6.82%

High Price Target

700.00USD

Spread / Highest target

+25.11%

Low Price Target

378.00USD

Spread / Lowest Target

-32.44%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wells Fargo Securities
Citigroup
Argus
William O'Neil & Co
Daiwa Securities
UBS
Rothschild & Co Redburn
HSBC
Raymond James
Goldman Sachs
Mizuho Securities
BTIG
Bernstein
Jefferies & Co.
Piper Sandler
Leerink Partners
Baird
Evercore ISI
JPMorgan Chase
RBC Capital Markets
Truist Securities
Deutsche Bank Securities
Redburn Atlantic
Barclays
Stifel Nicolaus
CICC Research
Mirae Asset Group
Morgan Stanley
Morningstar
BofA Securities
William Blair & Co.
Wolfe Research
Redburn
SVB Leerink
J.P. Morgan Chase
Oppenheimer